Cambridge: Researchers at the University of Cambridge have developed what they describe as the world’s first vaccine whose key component was designed entirely using artificial intelligence and then tested in human volunteers.
The experimental vaccine is designed to provide protection against a broad range of coronaviruses, including existing Covid-19 variants and related viruses that could potentially trigger future pandemics. Scientists say the technology represents a major shift in vaccine development by focusing on future threats rather than reacting to outbreaks after they emerge.
Instead of designing a vaccine around a single virus strain, researchers used artificial intelligence to analyse genetic data from multiple coronaviruses collected through global surveillance programmes. The AI then created a ‘super-antigen’ capable of training the immune system to recognise and respond to a wider family of viruses, even as they evolve through mutations.
The first human trial involved 39 participants and was primarily aimed at evaluating safety. Researchers reported encouraging early results, while a larger study involving around 200 volunteers is expected to provide further insights into how effectively the vaccine stimulates immune protection.
Findings published in the Journal of Infection described the immune response as modest but promising. Scientists involved in the project believe the same AI-driven approach could eventually be used to develop universal vaccines for influenza, bird flu and viral haemorrhagic diseases such as Ebola.
Research is already under way on several of these candidates, highlighting the technology’s broader potential. Experts say artificial intelligence could dramatically accelerate vaccine discovery by helping researchers predict how the immune system will respond to different vaccine designs.
While further testing is needed before any product becomes widely available, the breakthrough is being viewed as an important step toward stronger global pandemic preparedness. The project has also attracted praise from leading scientists and policymakers, who believe AI could transform the future of medicine.
If successful, the technology may help create broader, longer-lasting vaccines that reduce the need for frequent updates and offer protection against emerging diseases before they become global health emergencies.
IMPORTANT | Victoria unveils tougher laws targeting illicit tobacco sales
